The Impact of the Cures Act: What Drug and Medical Device Companies Need to Know

Next Month

Kim Tyrrell-Knott, Member of the Firm, and Bradley S. Davidsen, an Associate, will co-present "The Impact of the Cures Act: What Drug and Medical Device Companies Need to Know" for the Regulatory Affairs Professionals Society (RAPS). 

The 21st Century Cures Act ("Cures Act") set forth a bold agenda for the Food and Drug Administration ("FDA").  It is imperative for drug and medical device manufacturers to understand the immediate impacts of the Cures Act as well as the future regulatory impact of new regulations and policies implemented by FDA in order for it to comply with provisions of the Cures Act.  In this session, participants will learn about these new laws, regulations, and upcoming administrative actions and have the ability to discuss the impact of the Trump Administration on the drug and medical device industries.